Utah Medical Products
UTMD
109 hedge funds and large institutions have $126M invested in Utah Medical Products in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 37 reducing their positions, and 17 closing their positions.
0.29% more ownership
Funds ownership: 68% → 68.29% (+0.29%)
5% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 37
3% less funds holding
Funds holding: 112 → 109 (-3)
11% less capital invested
Capital invested by funds: $142M → $126M (-$16.2M)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$4.75M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$1.59M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$952K |
| 4 |
EHC
Everett Harris & Co
Los Angeles,
California
|
+$786K |
| 5 |
HCM
Huber Capital Management
El Segundo,
California
|
+$668K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.34M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$5.21M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$2.56M |
| 4 |
Morgan Stanley
New York
|
-$631K |
| 5 |
KPP
Kings Path Partners
Sugar Land,
Texas
|
-$523K |
UTMD Hedge Fund Activity: Q1 2025 in Review
109 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2025, worth a combined $126M — down 11% from $142M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of UTMD and 14 opened new positions — a net loss of 3 holders — while 37 trimmed existing stakes and 35 added.
The largest buyer was Brandes Investment Partners, adding an estimated $4.75M. The largest seller was Fidelity Investments, cutting an estimated $5.34M.
- 109 institutional investors held Utah Medical Products (UTMD) as of Q1 2025, down from 112 in Q4 2024.
- Funds reported $126M of Utah Medical Products stock for Q1 2025, down 11% quarter-over-quarter.
- 14 funds opened new Utah Medical Products positions in Q1 2025 and 17 closed out, a net change of -3 holders.
- The largest Utah Medical Products buyer in Q1 2025 was Brandes Investment Partners, an estimated $4.75M added.
- The largest Utah Medical Products seller in Q1 2025 was Fidelity Investments, an estimated $5.34M sold.
Based on aggregated 13F filings for Q1 2025.